Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of PPAR-Delta Agonist on Lipoprotein Kinetics in Metabolic Syndrome

NCT00841217 is registered in ClinicalTrials.gov with The University of Western Australia as lead sponsor.

NCT NCT00841217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00841217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of PPAR-Delta Agonist on Lipoprotein Kinetics in Metabolic Syndrome
Lead sponsor
The University of Western Australia
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
December 31, 2008
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, lipid disorders, obesity